Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy

Movement Disorders

Volumn 27, Issue 14, 2012, Pages 1754-1762

  Massey, Luke A ^a,b   Micallef, Caroline ^c   Paviour, Dominic C ^a   O'Sullivan, Sean S ^a,b   Ling, Helen ^a,b   Williams, David R ^d   Kallis, Constantinos ^e   Holton, Janice L ^a   Revesz, Tamas ^a   Burn, David J ^f   Yousry, Tarek ^c   Lees, Andrew J ^a,b   Fox, Nick C ^a   Jäger, Hans R ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d MONASH UNIVERSITY   (Australia)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Conventional MRI; Multiple system atrophy; Pathological confirmation; Progressive supranuclear palsy

Indexed keywords

ADULT; AGED; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MIDDLE CEREBELLAR PEDUNCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RADIODIAGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84871768775     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.24968     Document Type: Article

References (39)

1. Williams DR, Holton JL, Strand C, et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 2007; 130( Pt 6): 1566-1576.
2. Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol 2004; 3: 93-103.
3. Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 2003; 210: 57-60.
4. Oba H, Yagishita A, Terada H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005; 64: 2050-2055.
5. Adachi M, Kawanami T, Ohshima H, Sugai Y, Hosoya T. Morning glory sign: a particular MR finding in progressive supranuclear palsy. Magn Reson Med Sci 2004; 3: 125-132.
6. Mori H, Aoki S, Ohtomo K. Morning glory sign is not prevalent in progressive supranuclear palsy. Magn Reson Med Sci 2004; 3: 215; author reply 216-217.
7. Schrag A, Kingsley D, Phatouros C, et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998; 65: 65-71.
8. Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000; 54: 697-702.
9. Bhattacharya K, Saadia D, Eisenkraft B, et al. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol 2002; 59: 835-842.
10. Seppi K, Schocke MF, Wenning GK, Poewe W. How to diagnose MSA early: the role of magnetic resonance imaging. J Neural Transm 2005; 112: 1625-1634.
11. Uchino A, Sawada A, Takase Y, Kudo S. Symmetrical lesions of the middle cerebellar peduncle: MR imaging and differential diagnosis. Magn Reson Med Sci 2004; 3: 133-140.
12. Savoiardo M. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging. Neurol Sci 2003; 24( Suppl 1): S35-S37.
13. Seppi K, Schocke MF. An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism. Curr Opin Neurol 2005; 18: 370-375.
14. Yekhlef F, Ballan G, Macia F, Delmer O, Sourgen C, Tison F. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. J Neural Transm 2003; 110: 151-169.
15. Josephs KA, Tang-Wai DF, Edland SD, et al. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch Neurol 2004; 61: 1881-1884.
16. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125( Pt 4): 861-870.
17. Aiba I, Hashizume Y, Yoshida M, Okuda S, Murakami N, Ujihira N. Relationship between brainstem MRI and pathological findings in progressive supranuclear palsy-study in autopsy cases. J Neurol Sci 1997; 152: 210-217.
18. Yagishita A, Oda M. Progressive supranuclear palsy: MRI and pathological findings. Neuroradiology 1996; 38( Suppl 1): S60-S66.
19. Slowinski J, Imamura A, Uitti RJ, et al. MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol 2008; 255: 37-44.
20. Trojanowski JQ, Revesz T. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 2007; 33: 615-620.
21. Ince PG, Clarke B, Holton JL, Revesz T, Wharton S. Disorders of movement and system degenerations. In: Love S, Louis DN, Ellison DW, eds. Greenfield's Neuropathology. Vol. 1. 8th ed. London: Hodder Arnold Publishers; 2008: 889-1030.
22. Altman DG, Bland JM. Diagnostic tests. 2: predictive values. BMJ 1994; 309: 102.
23. Altman DG, Bland JM. Diagnostic tests. 1: Sensitivity and specificity. BMJ 1994; 308: 1552.
24. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005; 128( Pt 6): 1247-1258.
25. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
26. Righini A, Antonini A, De Notaris R, et al. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol 2004; 25: 927-932.
27. Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004; 127( Pt 12): 2657-2671.
28. Osaki Y, Wenning GK, Daniel SE, et al. Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 2002; 59: 1486-1491.
29. Muqit MM, Mort D, Miskiel KA, Shakir RA. "Hot cross bun" sign in a patient with parkinsonism secondary to presumed vasculitis. J Neurol Neurosurg Psychiatry 2001; 71: 565-566.
30. Burk K, Skalej M, Dichgans J. Pontine MRI hyperintensities ("the cross sign") are not pathognomonic for multiple system atrophy (MSA). Mov Disord 2001; 16: 535.
31. Murata Y, Yamaguchi S, Kawakami H, et al. Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Arch Neurol 1998; 55: 33-37.
32. Lee YC, Liu CS, Wu HM, Wang PS, Chang MH, Soong BW. The 'hot cross bun' sign in the patients with spinocerebellar ataxia. Eur J Neurol 2009; 16: 513-516.
33. Soares-Fernandes JP, Ribeiro M, Machado A. "Hot cross bun" sign in variant Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 2009;30:E37.
34. Slavin KV, Thulborn KR, Wess C, Nersesyan H. Direct visualization of the human subthalamic nucleus with 3T MR imaging. AJNR Am J Neuroradiol 2006; 27: 80-84.
35. Vaillancourt DE, Spraker MB, Prodoehl J, et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009; 72: 1378-1384.
36. Martin WR, Wieler M, Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008;70(16 Pt 2):1411-1417.
37. Quattrone A, Nicoletti G, Messina D, et al. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008; 246: 214-221.
38. Josephs KA, Whitwell JL, Dickson DW, et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 2008; 29: 280-289.
39. Messina D, Cerasa A, Condino F, et al. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord 2011; 17: 172-176.